CYP2D6 Genotype on the Clinical Effect of Tamoxifen
The purpose of this study is to investigate the impact of CYP2D6 Genotype on the clinical effects of tamoxifen using with samples from prospective randomized multicenter study(ASTRRA).
Breast Neoplasms|Tamoxifen|Genotype|CYP2D6
DRUG: Tamoxifen
Disease-free survival(DFS), 5years
The purpose of this study is to investigate the impact of CYP2D6 Genotype on the clinical effects of tamoxifen using with samples from prospective randomized multicenter study(ASTRRA).